Go Pro

62,394 Shares in Humana Inc. $HUM Acquired by Public Employees Retirement System of Ohio

Humana logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Public Employees Retirement System of Ohio acquired 62,394 Humana shares worth approximately $24.8 million, taking a roughly 0.05% stake. Institutional investors collectively own 92.38% of Humana.
  • Humana’s latest quarterly results exceeded expectations, with earnings of $7.61 per share versus the $7.27 consensus and revenue of $40.89 billion, up 26.2% year over year.
  • Shares opened at $386.92, while analysts maintained a consensus “Hold” rating and an average price target of $403.91.
  • MarketBeat previews top five stocks to own in September.

Public Employees Retirement System of Ohio bought a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 62,394 shares of the insurance provider's stock, valued at approximately $24,784,000. Public Employees Retirement System of Ohio owned about 0.05% of Humana at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in Humana during the second quarter valued at $4,138,160,000. Capital International Investors increased its position in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider's stock worth $1,490,239,000 after buying an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC increased its position in Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider's stock worth $948,614,000 after buying an additional 1,398,774 shares in the last quarter. State Street Corp raised its stake in shares of Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider's stock worth $1,403,877,000 after buying an additional 97,211 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Humana by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider's stock valued at $812,540,000 after buying an additional 23,732 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Stock Down 1.5%

Shares of HUM opened at $386.92 on Friday. The business's 50 day moving average is $385.60 and its 200 day moving average is $288.47. The company has a market capitalization of $46.46 billion, a PE ratio of 36.61, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period in the prior year, the company posted $6.27 EPS. The firm's revenue for the quarter was up 26.2% compared to the same quarter last year. Research analysts expect that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

HUM has been the subject of a number of recent research reports. Oppenheimer reiterated an "outperform" rating and set a $405.00 price objective on shares of Humana in a research note on Thursday, July 30th. Weiss Ratings raised shares of Humana from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, August 14th. Seaport Research Partners lowered shares of Humana to a "neutral" rating in a research report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Humana in a research report on Thursday, July 30th. They issued a "hold" rating for the company. Finally, TD Cowen raised their price objective on shares of Humana from $350.00 to $370.00 and gave the company a "hold" rating in a research report on Friday, July 31st. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $403.91.

Read Our Latest Report on Humana

About Humana

(Free Report)

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Featured Articles

Institutional Ownership by Quarter for Humana (NYSE:HUM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines